Open AccessGlibenclamide therapy: pros and cons
Author(s) -
Ольга Константиновна Викулова,
Викулова Ольга Константиновна,
Marina Shestakova,
Шестакова Марина Владимировна
Publication year - 2011
Publication title -
saharnyj diabet
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 12
eISSN - 2072-0378
pISSN - 2072-0351
DOI - 10.14341/2072-0351-6231
Subject(s) - medicine , glimepiride , glibenclamide , gliclazide , myocardial infarction , cons , intensive care medicine , diabetes mellitus , traditional medicine , endocrinology , type 2 diabetes , computer science , programming language
The safety of antidiabetic medications has received much attention in the resent past. Although concerns on the safety of glibenclamide therapy iscontroversial, some studies showed an increased risk of cardiovascular morbidity (f.e. myocardial infarction) and risk of mortality in subjects usingglibenclamide, but not other SU (gliclazide or glimepiride)